Shopping Cart 0
Cart Subtotal
USD 0

Bone Growth Stimulators - Medical Devices Pipeline Assessment, 2018

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2500

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 5000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 7500
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Bone Growth Stimulators-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Bone Growth Stimulators-Medical Devices Pipeline Assessment, 2018" provides an overview of Bone Growth Stimulators currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bone Growth Stimulators pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Bone Growth Stimulators under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Bone Growth Stimulators and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry.

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Bone Growth Stimulators under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date.

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 7

2 Introduction 7

2.1 Bone Growth Stimulators Overview 7

3 Products under Development 8

3.1 Bone Growth Stimulators-Pipeline Products by Stage of Development 8

3.2 Bone Growth Stimulators-Pipeline Products by Segment 9

3.3 Bone Growth Stimulators-Pipeline Products by Territory 10

3.4 Bone Growth Stimulators-Pipeline Products by Regulatory Path 11

3.5 Bone Growth Stimulators-Pipeline Products by Estimated Approval Date 12

3.6 Bone Growth Stimulators-Ongoing Clinical Trials 13

4 Bone Growth Stimulators-Pipeline Products under Development by Companies 14

4.1 Bone Growth Stimulators Companies-Pipeline Products by Stage of Development 14

4.2 Bone Growth Stimulators-Pipeline Products by Stage of Development 15

5 Bone Growth Stimulators Companies and Product Overview 16

5.1 Bionext Biotech Products Ltd. Company Overview 16

5.2 Centro de Investigacion Biomedica en Red en Bioingenieria Biomateriales y Nanomedicina Company Overview 17

5.3 Curative Biosciences, Inc. Company Overview 18

5.4 DJO Global Inc Company Overview 20

5.5 GreenBone Ortho srl Company Overview 23

5.6 Inion Oy Company Overview 26

5.7 Johns Hopkins University Company Overview 27

5.8 KeraCure, Inc. (Inactive) Company Overview 28

5.9 Lattice Biologics Ltd Company Overview 29

5.10 Locate Therapeutics Ltd Company Overview 30

5.11 NDSU Research Foundation Company Overview 31

5.12 Oklahoma State University Company Overview 32

5.13 Orthocell Ltd Company Overview 33

5.14 Orthofix International N.V. Company Overview 34

5.15 OsteoGenix Incorporated (Inactive) Company Overview 41

5.16 REGENECURE Ltd Company Overview 42

5.17 Texas A&M University Company Overview 43

5.18 Tornier Inc Company Overview 44

5.19 Universiti Putra Malaysia Company Overview 45

5.20 University of Florida Company Overview 46

5.21 University of Nottingham Company Overview 47

5.22 Zimmer Biomet Holdings Inc Company Overview 48

6 Bone Growth Stimulators- Recent Developments 50

6.1 Jul 10, 2018: Stryker announces organizational changes 50

6.2 Jul 05, 2018: CollPlant Names Dr. Wolfgang Ruttenstorfer As Board Director 50

6.3 Jun 25, 2018: Zimmer Biomet Update on Warsaw North Campus FDA Inspection 51

6.4 Jun 19, 2018: CollPlant Appoints Professor Shay Soker from Wake Forest Institute for Regenerative Medicine to its Scientific Advisory Board 51

6.5 Jun 05, 2018: Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value 52

7 Appendix 117

7.1 Methodology 117

7.2 About GlobalData 120

7.3 Contact Us 120

7.4 Disclaimer 120


List Of Figure

1.2 List of Figures

Figure 1: Bone Growth Stimulators-Pipeline Products by Stage of Development 9

Figure 2: Bone Growth Stimulators-Pipeline Products by Segment 10

Figure 3: Bone Growth Stimulators-Pipeline Products by Territory 11

Figure 4: Bone Growth Stimulators-Pipeline Products by Regulatory Path 12

Figure 5: Bone Growth Stimulators-Pipeline Products by Estimated Approval Date 13

Figure 6: Bone Growth Stimulators-Ongoing Clinical Trials 14


List Of Table

1.1 List of Tables

Table 1: Bone Growth Stimulators-Pipeline Products by Stage of Development 9

Table 2: Bone Growth Stimulators-Pipeline Products by Segment 10

Table 3: Bone Growth Stimulators-Pipeline Products by Territory 11

Table 4: Bone Growth Stimulators-Pipeline Products by Regulatory Path 12

Table 5: Bone Growth Stimulators-Pipeline Products by Estimated Approval Date 13

Table 6: Bone Growth Stimulators-Ongoing Clinical Trials 14

Table 7: Bone Growth Stimulators Companies-Pipeline Products by Stage of Development 15

Table 8: Bone Growth Stimulators-Pipeline Products by Stage of Development 16

Table 9: Bionext Biotech Products Ltd. Pipeline Products & Ongoing Clinical Trials Overview 17

Table 10: Orthonext-Product Status 17

Table 11: Orthonext-Product Description 17

Table 12: Centro de Investigacion Biomedica en Red en Bioingenieria Biomateriales y Nanomedicina Pipeline Products & Ongoing Clinical Trials Overview 18

Table 13: Bioactive Glass Scaffolds-Product Status 18

Table 14: Bioactive Glass Scaffolds-Product Description 18

Table 15: Curative Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 19

Table 16: Nurture BSP-Product Status 19

Table 17: Nurture BSP-Product Description 19

Table 18: Osteoconductive Scaffold-Product Status 20

Table 19: Osteoconductive Scaffold-Product Description 20

Table 20: DJO Global Inc Pipeline Products & Ongoing Clinical Trials Overview 21

Table 21: CMF OL1000-Fresh Ankle Fracture-Product Status 21

Table 22: CMF OL1000-Fresh Ankle Fracture-Product Description 21

Table 23: DJO Global Inc-Ongoing Clinical Trials Overview 22

Table 24: CMF OL1000-Fresh Ankle Fracture-Prospective, Randomized, Double-blinded, Controlled Multi-center Clinical Trial Evaluating the Use of Non-invasive CMF Bone Stimulation as Adjunct to Surgical Treatment of Ankle Fractures 23

Table 25: GreenBone Ortho srl Pipeline Products & Ongoing Clinical Trials Overview 24

Table 26: GreenBone Implant-Product Status 24

Table 27: GreenBone Implant-Product Description 24

Table 28: GreenBone Ortho srl-Ongoing Clinical Trials Overview 25

Table 29: GreenBone Implant-A Pre-market Multicenter National Open Label Single Arm Study to Evaluate the Safety and Performance of a Class III Medical Device (Greenbone Implant) for Iliac Crest Reconstruction Following Bone Graft Harvesting for Pelvic Fusion 26

Table 30: Inion Oy Pipeline Products & Ongoing Clinical Trials Overview 27

Table 31: Inion OptimaPLUS-Product Status 27

Table 32: Inion OptimaPLUS-Product Description 27

Table 33: Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 28

Table 34: 3D-printed Bone Extracellular Matrix Scaffold-Product Status 28

Table 35: 3D-printed Bone Extracellular Matrix Scaffold-Product Description 28

Table 36: KeraCure, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 29

Table 37: KeraPac-Bone Regeneration-Product Status 29

Table 38: KeraPac-Bone Regeneration-Product Description 29

Table 39: Lattice Biologics Ltd Pipeline Products & Ongoing Clinical Trials Overview 30

Table 40: Bone Scaffold + ECM-Product Status 30

Table 41: Bone Scaffold + ECM-Product Description 30

Table 42: Locate Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

Table 43: Injectable Bone Graft-Product Status 31

Table 44: Injectable Bone Graft-Product Description 31

Table 45: NDSU Research Foundation Pipeline Products & Ongoing Clinical Trials Overview 32

Table 46: Bone Scaffold-Product Status 32

Table 47: Bone Scaffold-Product Description 32

Table 48: Oklahoma State University Pipeline Products & Ongoing Clinical Trials Overview 33

Table 49: Bone Repair Scaffold-Product Status 33

Table 50: Bone Repair Scaffold-Product Description 33

Table 51: Orthocell Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

Table 52: CelGro SMRT Graft-Bone Repair-Product Status 34

Table 53: CelGro SMRT Graft-Bone Repair-Product Description 34

Table 54: Orthofix International N.V. Pipeline Products & Ongoing Clinical Trials Overview 35

Table 55: Cervical-Stim Osteogenesis Stimulator-Odontoid Fractures-Product Status 35

Table 56: Cervical-Stim Osteogenesis Stimulator-Odontoid Fractures-Product Description 36

Table 57: Physio-Stim Osteogenesis Stimulator-Osteoarthritis-Product Status 36

Table 58: Physio-Stim Osteogenesis Stimulator-Osteoarthritis-Product Description 36

Table 59: RCStim Device-Product Status 37

Table 60: RCStim Device-Product Description 37

Table 61: Orthofix International N.V.-Ongoing Clinical Trials Overview 38

Table 62: Cervical-Stim Osteogenesis Stimulator-Odontoid Fractures-A Multi-center, Open-label, Prospective Study of CervicalStim Device as Adjunctive Care Following Cervical Fusion 39

Table 63: Cervical-Stim Osteogenesis Stimulator-Odontoid Fractures-Safety and Efficacy of Pulsed Electromagnetic Fields (Cervical-Stim) as an Adjunct to Enhance Union in Conservatively Treated Type II Fractures of the Odontoid Process 39

Table 64: Physio-Stim Osteogenesis Stimulator-Osteoarthritis-A Prospective, Randomized, Double-blind, Placebo Controlled Study to Evaluate Efficacy and Safety of an Active Pulsed Electromagnetic Field for the Treatment of Osteoarthritis of the Knee 40

Table 65: RCStim Device-Prospective, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Efficacy of Pulsed Electromagnetic Field (PEMF) Therapy as an Adjunctive Treatment to Surgical Repair of Full Thickness Rotator Cuff Tears 41

Table 66: OsteoGenix Incorporated (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 42

Table 67: Bone Anabolic Agent-Product Status 42

Table 68: Bone Anabolic Agent-Product Description 42

Table 69: REGENECURE Ltd Pipeline Products & Ongoing Clinical Trials Overview 43

Table 70: Regenecure AMCA GBR Bone Membrane Implant-Product Status 43

Table 71: Regenecure AMCA GBR Bone Membrane Implant-Product Description 43

Table 72: Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview 44

Table 73: Bioactive Foam Based Moldable Scaffold-Product Status 44

Table 74: Bioactive Foam Based Moldable Scaffold-Product Description 44

Table 75: Tornier Inc Pipeline Products & Ongoing Clinical Trials Overview 45

Table 76: Soft Tissue Graft-Product Status 45

Table 77: Soft Tissue Graft-Product Description 45

Table 78: Universiti Putra Malaysia Pipeline Products & Ongoing Clinical Trials Overview 46

Table 79: Nanocomposite Bone Scaffold-Product Status 46

Table 80: Nanocomposite Bone Scaffold-Product Description 46

Table 81: University of Florida Pipeline Products & Ongoing Clinical Trials Overview 47

Table 82: Bone Tissue Scaffold-Product Status 47

Table 83: Bone Tissue Scaffold-Product Description 47

Table 84: University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 48

Table 85: Injectable Bone-Product Status 48

Table 86: Injectable Bone-Product Description 48

Table 87: Zimmer Biomet Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 49

Table 88: OrthoPak III-Product Status 49

Table 89: OrthoPak III-Product Description 49

Table 90: SpinalPak III-Product Status 50

Table 91: SpinalPak III-Product Description 50

Table 92: Glossary 120

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Bionext Biotech Products Ltd., Orthonext; Centro de Investigacion Biomedica en Red en Bioingenieria Biomateriales y Nanomedicina, Bioactive Glass Scaffolds; Curative Biosciences, Inc., Nurture BSP; Curative Biosciences, Inc., Osteoconductive Scaffold; DJO Global Inc, CMF OL1000 - Fresh Ankle Fracture; GreenBone Ortho srl, GreenBone Implant; Inion Oy, Inion OptimaPLUS; Johns Hopkins University, 3D-printed Bone Extracellular Matrix Scaffold; KeraCure, Inc. (Inactive), KeraPac - Bone Regeneration; Lattice Biologics Ltd, Bone Scaffold + ECM; Locate Therapeutics Ltd, Injectable Bone Graft; NDSU Research Foundation, Bone Scaffold; Oklahoma State University, Bone Repair Scaffold; Orthocell Ltd, CelGro SMRT Graft - Bone Repair; Orthofix International N.V., Cervical-Stim Osteogenesis Stimulator - Odontoid Fractures; Orthofix International N.V., Physio-Stim Osteogenesis Stimulator - Osteoarthritis; Orthofix International N.V., RCStim Device; OsteoGenix Incorporated (Inactive), Bone Anabolic Agent; REGENECURE Ltd, Regenecure AMCA GBR Bone Membrane Implant; Texas A&;M University, Bioactive Foam Based Moldable Scaffold; Tornier Inc, Soft Tissue Graft; Universiti Putra Malaysia, Nanocomposite Bone Scaffold; University of Florida, Bone Tissue Scaffold; University of Nottingham, Injectable Bone; Zimmer Biomet Holdings Inc, OrthoPak III; Zimmer Biomet Holdings Inc, SpinalPak III


Companies

Bionext Biotech Products Ltd.

Centro de Investigacion Biomedica en Red en Bioingenieria Biomateriales y Nanomedicina

Curative Biosciences, Inc.

DJO Global Inc

GreenBone Ortho srl

Inion Oy

Johns Hopkins University

KeraCure, Inc.

Lattice Biologics Ltd

Locate Therapeutics Ltd

NDSU Research Foundation

Oklahoma State University

Orthocell Ltd

Orthofix International N.V.

OsteoGenix Incorporated

REGENECURE Ltd

Texas A&M University

Tornier Inc

Universiti Putra Malaysia

University of Florida

University of Nottingham

Zimmer Biomet Holdings Inc